gastroesophageal cancer Culmination Bio, Cofactor Genomics Team up on Study to Advance Immunotherapy Response Test Culmination will give Cofactor access to over 4.5 million biological samples to advance the firm's assay to predict immunotherapy response in 11 cancer types. Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer They plan to study the genomic, transcriptomic, and proteomic responses of gastroesophageal tumors following treatment with Merck's Keytruda. Gastric Cancer Cases Frequently Harbor Genetic Risk Variants, Suggesting Germline Testing Using panel sequence data for more than 500 esophagogastric cancer cases, researchers found pathogenic or likely pathogenic variants in almost 20 percent of those with gastric cancers. Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders. Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors Palmetto has expanded the local coverage determination for the Guardant360 liquid biopsy assay to be used with the majority of advanced solid tumors. Oct 18, 2018 Broad Institute Launches Patient-Partnered Cancer Research Non-Profit Organization May 31, 2018 Roche, Five Prime Therapeutics to Develop CDx Assays for Immuno-Oncology Drug Trials Apr 3, 2018 PGDx to Develop Liquid Biopsy Companion Dx for Five Prime Therapeutics' Drug Candidate Sep 22, 2017 FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications Dec 8, 2015 CAP, ASCP, ASCO Release New HER2 Testing Draft Guidelines for Gastric Cancer Breaking News Harbinger Health Raises $140 Million in Series B Financing BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis Evvy Closes $14M Series A for Vaginal Microbiome Testing, Launches Add-on STI Screen The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.